Ziprasidone Hydrochloride

Alzheimer's Disease, Schizophrenia, Agitation + 6 more

Treatment

3 FDA approvals

20 Active Studies for Ziprasidone Hydrochloride

What is Ziprasidone Hydrochloride

Ziprasidone

The Generic name of this drug

Treatment Summary

Disorders like schizophrenia and bipolar disorder can have a big impact on mood, thinking, and behavior. These mental illnesses can also cause depression and substance abuse. Treatment options for these psychotic disorders have been available since 1952, such as first and second generation antipsychotics. Ziprasidone is a second generation antipsychotic used to treat schizophrenia and bipolar disorder. It can help reduce the rate and time of relapses in schizophrenia and treat manic episodes in bipolar disorder. Compared to other second generation antipsychotics, it has a lower chance of causing metabolic side effects.

Geodon

is the brand name

image of different drug pills on a surface

Ziprasidone Hydrochloride Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Geodon

Ziprasidone

2001

250

Approved as Treatment by the FDA

Ziprasidone, also called Geodon, is approved by the FDA for 3 uses which include Bipolar 1 Disorder and Acute Coryza .

Bipolar 1 Disorder

Acute Coryza

Bipolar Disorder

Effectiveness

How Ziprasidone Hydrochloride Affects Patients

Ziprasidone is a type of antipsychotic medication that works by blocking certain receptors in the brain, including dopamine and serotonin. It also blocks the reuptake of serotonin and norepinephrine, which helps to prevent them from being absorbed back into the brain. Ziprasidone has a very high affinity for serotonin receptors but a low affinity for other types of receptors, such as those for histamine and adrenaline.

How Ziprasidone Hydrochloride works in the body

Ziprasidone works differently than other antipsychotics. It binds to serotonin-2A and dopamine D2 receptors in a similar way, but it has a higher affinity for the serotonin-2A receptor than other drugs. This means it has a better ability to improve mood, reduce negative symptoms, and improve cognition. It also has a lower risk of causing orthostatic hypotension, cognitive disturbance, sedation, weight gain, and disruption in prolactin levels. This is because it binds less strongly to histamine H1, muscarinic M1, and alpha1-adrenoceptors.

When to interrupt dosage

The suggested dosage of Ziprasidone Hydrochloride is contingent upon the diagnosed condition, for example Alzheimer's Disease, Bipolar Disorder and Acute Coryza. The magnitude of dosage fluctuates as per the delivery approach indicated in the table below.

Condition

Dosage

Administration

Alzheimer's Disease

20.0 mg, 40.0 mg, 60.0 mg, , 80.0 mg, 20.0 mg/mL

, Oral, Capsule - Oral, Capsule, Intramuscular, Injection, powder, lyophilized, for solution - Intramuscular, Injection, powder, lyophilized, for solution

Schizophrenia

20.0 mg, 40.0 mg, 60.0 mg, , 80.0 mg, 20.0 mg/mL

, Oral, Capsule - Oral, Capsule, Intramuscular, Injection, powder, lyophilized, for solution - Intramuscular, Injection, powder, lyophilized, for solution

Schizophrenia

20.0 mg, 40.0 mg, 60.0 mg, , 80.0 mg, 20.0 mg/mL

, Oral, Capsule - Oral, Capsule, Intramuscular, Injection, powder, lyophilized, for solution - Intramuscular, Injection, powder, lyophilized, for solution

Acute Coryza

20.0 mg, 40.0 mg, 60.0 mg, , 80.0 mg, 20.0 mg/mL

, Oral, Capsule - Oral, Capsule, Intramuscular, Injection, powder, lyophilized, for solution - Intramuscular, Injection, powder, lyophilized, for solution

Agitation

20.0 mg, 40.0 mg, 60.0 mg, , 80.0 mg, 20.0 mg/mL

, Oral, Capsule - Oral, Capsule, Intramuscular, Injection, powder, lyophilized, for solution - Intramuscular, Injection, powder, lyophilized, for solution

Bipolar Disorder

20.0 mg, 40.0 mg, 60.0 mg, , 80.0 mg, 20.0 mg/mL

, Oral, Capsule - Oral, Capsule, Intramuscular, Injection, powder, lyophilized, for solution - Intramuscular, Injection, powder, lyophilized, for solution

Unipolar Depression

20.0 mg, 40.0 mg, 60.0 mg, , 80.0 mg, 20.0 mg/mL

, Oral, Capsule - Oral, Capsule, Intramuscular, Injection, powder, lyophilized, for solution - Intramuscular, Injection, powder, lyophilized, for solution

Acute Agitation

20.0 mg, 40.0 mg, 60.0 mg, , 80.0 mg, 20.0 mg/mL

, Oral, Capsule - Oral, Capsule, Intramuscular, Injection, powder, lyophilized, for solution - Intramuscular, Injection, powder, lyophilized, for solution

Bipolar Disorder

20.0 mg, 40.0 mg, 60.0 mg, , 80.0 mg, 20.0 mg/mL

, Oral, Capsule - Oral, Capsule, Intramuscular, Injection, powder, lyophilized, for solution - Intramuscular, Injection, powder, lyophilized, for solution

Warnings

Ziprasidone Hydrochloride Contraindications

Condition

Risk Level

Notes

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Myocardial Infarction

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Heart Decompensation

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Long QT Syndrome

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Ziprasidone may interact with Pulse Frequency

There are 20 known major drug interactions with Ziprasidone Hydrochloride.

Common Ziprasidone Hydrochloride Drug Interactions

Drug Name

Risk Level

Description

Abemaciclib

Major

The metabolism of Abemaciclib can be decreased when combined with Ziprasidone.

Acalabrutinib

Major

The metabolism of Acalabrutinib can be decreased when combined with Ziprasidone.

Aclidinium

Major

The risk or severity of adverse effects can be increased when Ziprasidone is combined with Aclidinium.

Alectinib

Major

The metabolism of Alectinib can be decreased when combined with Ziprasidone.

Alpelisib

Major

The metabolism of Alpelisib can be decreased when combined with Ziprasidone.

Ziprasidone Hydrochloride Toxicity & Overdose Risk

Common side effects of taking ziprasidone can include sleepiness, respiratory infections, muscle stiffness, dizziness, restlessness, blurry vision, exhaustion, vomiting, headaches, and nausea.

image of a doctor in a lab doing drug, clinical research

Ziprasidone Hydrochloride Novel Uses: Which Conditions Have a Clinical Trial Featuring Ziprasidone Hydrochloride?

456 active clinical trials are underway to assess the potential of Ziprasidone Hydrochloride in alleviating Agitation, Alzheimer's Disease and Schizophrenia.

Condition

Clinical Trials

Trial Phases

Acute Agitation

0 Actively Recruiting

Bipolar Disorder

0 Actively Recruiting

Schizophrenia

31 Actively Recruiting

Early Phase 1, Not Applicable, Phase 4

Alzheimer's Disease

112 Actively Recruiting

Phase 2, Phase 3, Not Applicable, Phase 1, Phase 4, Early Phase 1

Bipolar Disorder

0 Actively Recruiting

Acute Coryza

1 Actively Recruiting

Not Applicable

Unipolar Depression

0 Actively Recruiting

Agitation

3 Actively Recruiting

Phase 2, Phase 3, Not Applicable

Schizophrenia

97 Actively Recruiting

Phase 3, Not Applicable, Early Phase 1, Phase 4, Phase 1, Phase 2

Ziprasidone Hydrochloride Reviews: What are patients saying about Ziprasidone Hydrochloride?

5

Patient Review

8/12/2014

Ziprasidone Hydrochloride for Agitation associated with Schizophrenia

5

Patient Review

11/20/2020

Ziprasidone Hydrochloride for Mania associated with Bipolar Disorder

I started taking this medication in addition to my depression medication, as it was supposed to help improve my mood. Unfortunately, I began hallucinating soon after starting the medication. It took me a few months to realize that the hallucinations were caused by the ziprasidone. Thankfully, I had a GeneSight test which helped me identify the problem. I start my new medications tomorrow and hopefully will see some improvement.

4.7

Patient Review

10/25/2015

Ziprasidone Hydrochloride for Mania associated with Bipolar Disorder

I've been on 60 mg for three weeks now. I'm supposed to take one in the morning and one with dinner, but the morning pill makes me so sleepy that I can't function. If I take the dinner pill too late, then I can get up in the morning. The good news is that I haven't had any manic episodes; however, the bad news is that my sex drive has totally disappeared.

2.7

Patient Review

1/7/2016

Ziprasidone Hydrochloride for Schizophrenia

I was on Quetiapine before this Medication and the difference is huge, I'm feeling more energetic and my depression has lifted. Instead of sleeping close to 15 hours most days I'm now happy with 8-9 hours sleep. My thinking is clearer and overall I feel in a better space.

2.7

Patient Review

8/24/2014

Ziprasidone Hydrochloride for Schizophrenia

Unfortunately, this medication caused a lot of weight gain and other problems like tremors, mouth sores, and fatigue.

2.3

Patient Review

8/19/2014

Ziprasidone Hydrochloride for Mania associated with Bipolar Disorder

I've only been taking this medication for a short while, but it's already helped me. The only downside is that I've developed twitching in my facial muscles.

1.7

Patient Review

8/1/2020

Ziprasidone Hydrochloride for Additional Medications to Treat Depression

I have now tried this treatment four times. I suffer from bi-polar type one with mixed episodes and Geodon has always helped me in the past. I alternate between taking Saphris and Geodon when I build up a tolerance to one or the other. I am currently taking 60mg, but have been as high as 120mg before with no problems.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about ziprasidone hydrochloride

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does ziprasidone help you sleep?

"A sleep study of 12 healthy men showed that those treated with ziprasidone had better sleep continuity and efficiency, less REM sleep, and more stage 2 sleep and slow wave sleep than those who did not receive the treatment."

Answered by AI

What type of medication is ziprasidone hydrochloride?

"Ziprasidone is a type of antipsychotic medication that works by changing the activity of certain natural substances in the brain."

Answered by AI

What is the side effect of ziprasidone hydrochloride?

"The following side effects may occur with this medication: drowsiness, dizziness, lightheadedness, weakness, nausea, vomiting, runny nose, and cough. If you experience any of these side effects, tell your doctor. Dizziness and lightheadedness can increase your risk of falling."

Answered by AI

What is Ziprasidone Hydrochloride used for?

"Ziprasidone is a medication used to treat symptoms associated with mental disorders such as schizophrenia, mania, or bipolar disorder. It is not to be used in elderly patients who suffer from behavioral problems related to dementia. Ziprasidoneadjusts the levels of certain chemicals in the brain in order to alleviate psychotic disorders."

Answered by AI

Clinical Trials for Ziprasidone Hydrochloride

Image of Connecticut Mental Health Clinic in New Haven, United States.

Treatment for Alzheimer's Disease

50 - 80
All Sexes
New Haven, CT

This study aims to provide mechanistic insights into how group drumming as a music-based intervention (MBI) affects pain responses and nociceptive function in individuals with Alzheimer's Disease (AD), mild dementia or mild cognitive impairment (MCI). Heart rate (HR), heart rate variability (HRV), and brain activity will be measured during communal drumming with their dyadic partners and others. Brain activity, blood pressure, cognitive abilities, blood hormone levels, and static and dynamic pain will also be measured during sessions pre and post the 8-week community drum circle. Investigators will leverage various measurement techniques including, but not limited to, electroencephalography (EEG), quantitative sensory testing (QST), behavioral, surveys, and physiological monitoring to study the impact of group drumming on pain and brain activity in AD and inter-dyad synchrony.

Recruiting
Has No Placebo

Connecticut Mental Health Clinic

AZA Allsop, MD, PhD

Have you considered Ziprasidone Hydrochloride clinical trials?

We made a collection of clinical trials featuring Ziprasidone Hydrochloride, we think they might fit your search criteria.
Go to Trials

Have you considered Ziprasidone Hydrochloride clinical trials?

We made a collection of clinical trials featuring Ziprasidone Hydrochloride, we think they might fit your search criteria.
Go to Trials
Image of Johns Hopkins Community Physicians in Baltimore, United States.

e-ALIGN for Cognitive Impairment

65+
All Sexes
Baltimore, MD

The overarching goal of this study is to pilot an intervention in which older adults with mild cognitive impairment and dementia and the older adult's care partners are identified in primary care and provided with educational materials through the patient portal to engage the participant in deprescribing. The multicomponent intervention, e-Align, includes delivery of educational information through the patient portal, and a pharmacist-led intervention to align medications with patient and care partner goals and reduce use of central nervous system (CNS) potentially inappropriate medicines (PIM). This work will establish the preliminary data, methods, and partnerships to undertake a multisite embedded pragmatic clinical trial. The resulting triadic-based behavioral intervention will promote patient and care partner engagement, and foster care that aligns with patients' values, and promote improved health and well-being outcomes for people with cognitive impairment and the patient's care partners through deprescribing.

Recruiting
Has No Placebo

Johns Hopkins Community Physicians

Ariel Green, MD, MPH, PhD

Image of University of Kansas Medical Center in Fairway, United States.

Ketogenic Diet for Osteoarthritis Pain

55 - 75
All Sexes
Fairway, KS

Osteoarthritis and mild cognitive impairment are common conditions that share underlying biological processes related to metabolism and inflammation. This study will examine whether a well-formulated ketogenic diet influences pain, physical function, and cognitive outcomes in adults with osteoarthritis and mild cognitive impairment. Participants will follow a supervised ketogenic dietary intervention, with assessments conducted before and after the intervention to evaluate changes in symptoms and related biological markers. The goal of this study is to better understand shared mechanisms between joint pain and cognitive health and to explore whether a ketogenic dietary approach may support symptom management in these populations.

Waitlist Available
Has No Placebo

University of Kansas Medical Center

Have you considered Ziprasidone Hydrochloride clinical trials?

We made a collection of clinical trials featuring Ziprasidone Hydrochloride, we think they might fit your search criteria.
Go to Trials